{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:17:02Z","timestamp":1792459022736,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Dublin, Trinity College"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Adrenal myelolipomas are rare, benign, tumours of the adrenal cortex.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>This study reports the experience of a tertiary adrenal surgery referral centre\u2019s approach to the management of patients with adrenal myelolipoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective observational cohort study was conducted on all adult patients (&gt;\u200918\u00a0years age) diagnosed with adrenal myelolipoma from January 1, 2014, to December 30, 2022. Demographics, imaging characteristics, histological diagnosis (where applicable) and follow-up data were compared between patients undergoing surgery and those referred to surveillance. Indications for operative intervention were recorded at the time of multidisciplinary team discussion, consisting of surgeons, endocrinology physicians, radiologists, pathologists and specialist nursing representatives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 522 patients with an adrenal lesion discussed in adrenal tumour meeting between 2014 and 2022,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200915 (2.8%) were diagnosed with adrenal myelolipoma. Of the 15 patients, 4 underwent adrenalectomy at first presentation (27%), while 1 patient underwent adrenalectomy after interval follow-up. Indications for operative intervention were as follows: \u2018indeterminate lesion\u2019 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093), \u2018abdominal pain and size (&gt;\u20094\u00a0cm)\u2019 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091) and \u2018mass effect on adjacent organs\u2019 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091). The mean rate of lesion growth in patients referred for surveillance (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200910) was 0.13\u00a0cm\/year. Histology confirmed adrenal myelolipoma as the diagnosis in all resected tumours.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>For patients with adrenal myelolipoma, the presence of symptoms and\/or indeterminate features on imaging may be more clinically useful indications for operative intervention over size alone. The surveillance of adrenal myelolipomas, even in patients with adrenal lesions\u2009&gt;\u20094\u00a0cm, is a safe clinical strategy, provided the imaging characteristics are benign and patients remain asymptomatic.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11845-024-03779-2","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T04:02:41Z","timestamp":1725422561000},"page":"2941-2947","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Management of patients with adrenal myelolipoma: experience from a tertiary referral centre"],"prefix":"10.1007","volume":"193","author":[{"given":"Anant","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4858-4813","authenticated-orcid":false,"given":"Conor","family":"Toale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Egan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Feeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Crowther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Gibney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Conlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,4]]},"reference":[{"issue":"3","key":"3779_CR1","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1530\/ERC-16-0564","volume":"24","author":"AK Lam","year":"2017","unstructured":"Lam AK (2017) Lipomatous tumours in adrenal gland: WHO updates and clinical implications. Endocr Relat Cancer 24(3):R65\u2013R79","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"3779_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.urolonc.2009.03.027","volume":"29","author":"X Bin","year":"2011","unstructured":"Bin X et al (2011) Adrenal incidentalomas: experience from a retrospective study in a Chinese population. Urol Oncol: Semin Orig Inv 29(3):270\u2013274","journal-title":"Urol Oncol: Semin Orig Inv"},{"issue":"5","key":"3779_CR3","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.2214\/AJR.07.2799","volume":"190","author":"JH Song","year":"2008","unstructured":"Song JH, Chaudhry FS, Mayo-Smith WW (2008) The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol 190(5):1163\u20131168","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"3779_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12020-017-1473-4","volume":"59","author":"A Decmann","year":"2018","unstructured":"Decmann A et al. (2018) Adrenal myelolipoma: a comprehensive review. Endocrine 59(1):7\u201315","journal-title":"Endocrine"},{"issue":"11","key":"3779_CR5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S2213-8587(21)00178-9","volume":"9","author":"J Calissendorff","year":"2021","unstructured":"Calissendorff J et al. (2021) Adrenal myelolipomas. Lancet Diabetes Endocrinol 9(11):767\u2013775","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3779_CR6","doi-asserted-by":"publisher","first-page":"107527","DOI":"10.1016\/j.ijscr.2022.107527","volume":"98","author":"X Steka","year":"2022","unstructured":"Steka X et al. (2022) Adrenal myelolipoma: defining the role of surgery. A case report. Int J Surg Case Rep 98:107527","journal-title":"International Journal of Surgery Case Reports"},{"issue":"1","key":"3779_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/cen.14188","volume":"93","author":"O Hamidi","year":"2020","unstructured":"Hamidi O et al. (2020) Clinical course of adrenal myelolipoma: a long-term longitudinal follow-up study. Clin Endocrinol 93(1):11\u201318","journal-title":"Clin Endocrinol"},{"issue":"4","key":"3779_CR8","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/S0022-5347(01)64926-7","volume":"157","author":"M Han","year":"1997","unstructured":"Han M et al. (1997) The natural history and treatment of adrenal myelolipoma. J Urol 157(4):1213\u20131216","journal-title":"J Urol"},{"issue":"2","key":"3779_CR9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s12020-017-1410-6","volume":"58","author":"MJ Campbell","year":"2017","unstructured":"Campbell MJ et al. (2017) The radiographically diagnosed adrenal myelolipoma: what do we really know? Endocrine 58(2):289\u2013294","journal-title":"Endocrine"},{"issue":"2","key":"3779_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4103\/0970-1591.152807","volume":"31","author":"VG Shenoy","year":"2015","unstructured":"Shenoy VG et al (2015) Adrenal myelolipoma: controversies in its management. Indian J Urol 31(2):94\u2013101","journal-title":"Indian J Urol"},{"issue":"1","key":"3779_CR11","first-page":"7","volume":"53","author":"SC Sieber","year":"1989","unstructured":"Sieber SC et al. (1989) Ectopic ACTH and adrenal myelolipoma. Conn Med 53(1):7\u201310","journal-title":"Conn Med"},{"issue":"6","key":"3779_CR12","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/S0022-5347(01)67307-5","volume":"153","author":"R Sanders","year":"1995","unstructured":"Sanders R et al. (1995) Clinical spectrum of adrenal myelolipoma: analysis of 8 tumors in 7 patients. J Urol 153(6):1791\u20131793","journal-title":"J Urol"},{"issue":"5","key":"3779_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1053\/crad.2000.0089","volume":"55","author":"CC Hoeffel","year":"2000","unstructured":"Hoeffel CC, Kowalski S (2000) Giant myelolipoma of the adrenal gland: natural history. Clin Radiol 55(5):1\u20133","journal-title":"Clin Radiol"},{"issue":"1","key":"3779_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1089\/lap.2013.0411","volume":"24","author":"VM Gershuni","year":"2014","unstructured":"Gershuni VM et al. (2014) Adrenal myelolipoma: operative indications and outcomes. J Laparoendosc Adv Surg Tech A 24(1):8\u201312","journal-title":"J Laparoendosc Adv Surg Tech A"},{"issue":"3","key":"3779_CR15","first-page":"241","volume":"61","author":"A Kiriakopoulos","year":"2006","unstructured":"Kiriakopoulos A, Tsakayannis D, Linos D (2006) Surgical management of adrenal myelolipoma: a series of 10 patients and review of the literature. Minerva Chir 61(3):241\u2013246","journal-title":"Minerva Chir"},{"key":"3779_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ijscr.2020.01.027","volume":"67","author":"AM Alkhalifa","year":"2020","unstructured":"Alkhalifa AM\u00a0et al.\u00a0(2020) Lipomatous tumors of adrenal gland: a case series of 5 patients and review of the literature. Int J Surg Case Rep 67:54\u201361","journal-title":"Int J Surg Case Rep"},{"issue":"4","key":"3779_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00423-019-01783-0","volume":"404","author":"F Weber","year":"2019","unstructured":"Weber F et al. (2019) Surgery for adrenal angiomyelolipoma: an individualized concept. Langenbecks Arch Surg 404(4):403\u2013409","journal-title":"Langenbecks Arch Surg"},{"issue":"8","key":"3779_CR18","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.ijscr.2014.04.001","volume":"5","author":"M Ramirez","year":"2014","unstructured":"Ramirez M, Misra S (2014) Adrenal myelolipoma: to operate or not? A case report and review of the literature. Int J Surg Case Rep 5(8):494\u2013496","journal-title":"Int J Surg Case Rep"},{"issue":"3\u20134","key":"3779_CR19","first-page":"E132","volume":"8","author":"J Zhao","year":"2014","unstructured":"Zhao J\u00a0et al.\u00a0(2014) The diagnosis and treatment of primary adrenal lipomatous tumours in Chinese patients: a 31-year follow-up study. Can Urol Assoc J 8(3\u20134):E132\u2013E136","journal-title":"Can Urol Assoc J"},{"issue":"2","key":"3779_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.beem.2009.04.001","volume":"23","author":"M Terzolo","year":"2009","unstructured":"Terzolo M et al. (2009) Management of adrenal incidentaloma. Best Pract Res Clin Endocrinol Metab 23(2):233\u2013243","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"3779_CR21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1507\/endocrj.EJ18-0486","volume":"67","author":"T Ichijo","year":"2020","unstructured":"Ichijo T\u00a0et al.\u00a0(2020) A nationwide survey of adrenal incidentalomas in Japan: the first report of clinical and epidemiological features. Endocr J 67(2):141\u2013152","journal-title":"Endocr J"},{"issue":"2","key":"3779_CR22","first-page":"637","volume":"85","author":"F Mantero","year":"2000","unstructured":"Mantero F et al. (2000) A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85(2):637\u201344","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"3779_CR23","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.2214\/AJR.07.2799","volume":"190","author":"JH Song","year":"2008","unstructured":"Song JH, Chaudhry FS, Mayo-Smith WW (2008) The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. Am J Roentgenol 190(5):1163\u20131168","journal-title":"Am J Roentgenol"},{"issue":"9","key":"3779_CR24","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1136\/jcp.54.9.707","volume":"54","author":"KY Lam","year":"2001","unstructured":"Lam KY, Lo CY (2001) Adrenal lipomatous tumours: a 30 year clinicopathological experience at a single institution. J Clin Pathol 54(9):707\u2013712","journal-title":"J Clin Pathol"},{"key":"3779_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.663346","volume":"8","author":"L Lin","year":"2021","unstructured":"Lin L\u00a0et al.\u00a0(2021) Adrenal myelolipoma: 369 cases from a high-volume center. Front Cardiovasc Med 8:663346","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"2","key":"3779_CR26","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1089\/end.2013.0283","volume":"28","author":"L Yin","year":"2014","unstructured":"Yin L\u00a0et al.\u00a0(2014) A 10-year single-center experience with surgical management of adrenal myelolipoma. J Endourol 28(2):252\u2013255","journal-title":"J Endourol"},{"issue":"2","key":"3779_CR27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4321\/S0004-06142007000200022","volume":"60","author":"OA Castillo","year":"2007","unstructured":"Castillo OA\u00a0et al.\u00a0(2007) Laparoscopic adrenalectomy for adrenal myelolipoma. Arch Esp Urol 60(2):217\u2013221","journal-title":"Arch Esp Urol"},{"issue":"2","key":"3779_CR28","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0467","volume":"175","author":"M Fassnacht","year":"2016","unstructured":"Fassnacht M\u00a0et al.\u00a0(2016) Management of adrenal incidentalomas: European Society of Endocrinology clinical practice guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 175(2):G1\u2013G34","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"3779_CR29","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.amjsurg.2012.02.009","volume":"204","author":"AL Melck","year":"2012","unstructured":"Melck AL\u00a0et al.\u00a0(2012) Immediate laparoscopic adrenalectomy versus observation: cost evaluation for incidental adrenal lesions with atypical imaging characteristics. Am J Surg 204(4):462\u2013467","journal-title":"Am J Surg"},{"issue":"2","key":"3779_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s12022-007-0019-3","volume":"18","author":"N Al-Brahim","year":"2007","unstructured":"Al-Brahim N, Asa S (2007) Myelolipoma with adrenocortical adenoma: an unusual combination that can resemble carcinoma. Endocr Pathol 18(2):103\u2013105","journal-title":"Endocr Pathol"},{"key":"3779_CR31","first-page":"4044602","volume":"2022","author":"DA Robinson","year":"2022","unstructured":"Robinson DA et al (2022) Adrenal myelolipoma masquerading as an adrenal malignancy. Case Rep Endocrinol Print 2022:4044602","journal-title":"Case Rep Endocrinol Print"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-024-03779-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-024-03779-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-024-03779-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T18:04:59Z","timestamp":1734977099000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-024-03779-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,4]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["3779"],"URL":"https:\/\/doi.org\/10.1007\/s11845-024-03779-2","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,4]]},"assertion":[{"value":"13 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was provided for this study from the Tallaght Hospital Research Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}